Literature DB >> 12084602

Noninvasive assessment of microvascular function in arterial hypertension by transthoracic Doppler harmonic echocardiography.

Thomas Bartel1, Ya Yang, Silvana Müller, René R Wenzel, Dietrich Baumgart, Thomas Philipp, Raimund Erbel.   

Abstract

OBJECTIVES: The present study sought to investigate the use of transthoracic Doppler harmonic echocardiography (TTDHE) to evaluate changes in coronary flow dynamics due to microvascular dysfunction.
BACKGROUND: Coronary flow velocity reserve (CFVR) measurements by TTDHE are useful for assessing epicardial coronary artery stenoses. It remains unclear, however, if microvascular disease can be detected.
METHODS: In 54 patients with chest pain, intracoronary Doppler (ICD) and TTDHE were used to measure average peak velocity at baseline and hyperemia. Significant coronary lesions had been ruled out by both angiography and intravascular ultrasound. Comparative measurements were performed in the distal left anterior descending coronary artery after intracoronary and intravenous administration of adenosine, and CFVR was calculated. Hypertensive patients (n = 25) were studied and compared to a control group (26 normotensive individuals).
RESULTS: Three patients (5%) had to be excluded because of insufficient image quality or side effects. In both groups, TTDHE-derived CFVR data correlated closely with ICD measurements (group 1: y = 0.67x + 0.076, standard error of estimate [SEE] = 0.25, r = 0.87, p < 0.001; group 2: y = 0.64x + 1.11, SEE = 0.26, r = 0.87, p < 0.001). CFVR was lower in hypertensives than in normotensive controls (2.44 +/- 0.49 vs. 3.33 +/- 0.40, p < 0.001, cut point = 2.84).
CONCLUSIONS: The newly described echocardiographic method is suitable for assessing microvascular dysfunction noninvasively and corresponds well to invasive measurements.

Entities:  

Mesh:

Year:  2002        PMID: 12084602     DOI: 10.1016/s0735-1097(02)01906-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

Review 1.  Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy.

Authors:  Jenna Dean; Sherwin Dela Cruz; Puja K Mehta; C Noel Bairey Merz
Journal:  Nat Rev Cardiol       Date:  2015-05-26       Impact factor: 32.419

2.  Myocardial strain indices and coronary flow reserve are only mildly affected in healthy hypertensive patients.

Authors:  Dimitrios Evangelou; Aris Bechlioulis; Georgios Tzeltzes; Lampros Lakkas; Ioanna Theodorou; Rigas Kalaitzidis; Evangelia Dounousi; Lampros K Michalis; Katerina K Naka
Journal:  Int J Cardiovasc Imaging       Date:  2020-07-30       Impact factor: 2.357

Review 3.  [Hypertensive heart disease and microangiopathy].

Authors:  M Kelm; B E Strauer
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

4.  Transthoracic echo-Doppler assessment of coronary microvascular function late after Kawasaki disease.

Authors:  S Cicala; M Galderisi; M Grieco; A Lamberti; R Cosimi; F Pellegrini; F de Leva
Journal:  Pediatr Cardiol       Date:  2007-08-28       Impact factor: 1.655

Review 5.  Angina, "normal" coronary angiography, and vascular dysfunction: risk assessment strategies.

Authors:  Raffaele Bugiardini; Lina Badimon; Peter Collins; Raimund Erbel; Kim Fox; Christian Hamm; Fausto Pinto; Annika Rosengren; Christodoulos Stefanadis; Lars Wallentin; Frans Van de Werf
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

6.  Low density lipoprotein cholesterol level inversely correlated with coronary flow velocity reserve in patients with Type 2 diabetes.

Authors:  Jie Yu; Jiang-Li Han; Li-Yun He; Xin-Heng Feng; Wei-Hong Li; Jie-Ming Mao; Wei Gao; Guang Wang
Journal:  J Geriatr Cardiol       Date:  2013-06       Impact factor: 3.327

7.  The impact of aging and atherosclerotic risk factors on transthoracic coronary flow reserve in subjects with normal coronary angiography.

Authors:  Maurizio Galderisi; Fausto Rigo; Sonia Gherardi; Lauro Cortigiani; Ciro Santoro; Rosa Sicari; Eugenio Picano
Journal:  Cardiovasc Ultrasound       Date:  2012-05-14       Impact factor: 2.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.